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Abstracts / Urological Science 27 (2016) S1eS23S4Conclusion: Our results demonstrate that miR-30a-5p can sensitize BC
cells to cisplatin via suppressing ATG5 and BECN1 expression, therefore,
increasing miR-30a-5p level in BC represents a novel strategy to enhance
the efﬁcacy of cisplatin therapy during cancer treatment.
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Purpose: Increased urinary tract malignancy has been reported in end-
stage renal disease (ESRD). However, little is known about chronic kidney
disease (CKD). This study is designed to explore the association between
CKD and upper tract urothelial carcinoma (UTUC).
Materials and Methods: Using Taiwan's Longitudinal Health Insurance
Database, we studied CKD patients between January 2000 and December
2011. The non-CKD controls were selected at a ratio of 4:1 and frequency
matched by gender, age group and index date.We used Chi-square test and
t-test to analyze the sociodemographic information and comorbidities.
Cox regression analysis was used to calculate the hazard ratio (HR) and 95%
conﬁdence interval (CI).
Results: The selected cases included 45,321 CKD cases and 181,284 con-
trols. A signiﬁcantly higher incidence of UTUC was noted in the CKD group
(0.22% vs. 0.07%, p< 0.001). In univariate analysis, CKD, female gender, age,
hypertension, hematuria, repeated urinary tract infection, bladder cancer
and ESRD were all associated with UTUC. In multivariate analysis, only
CKD, female gender, age, hematuria, bladder cancer and ESRD were
signiﬁcantly associated. The HR for CKD was 1.63 (95% CI: 1.26e2.13). Fe-
males had a higher HR of 1.38 (95% CI: 1.11e1.71). After excluding those
patients who progressed to dialysis or kidney transplantation, the risk for
CKD was still high, with a HR of 1.72 (95% CI: 1.33e2.33).
Conclusion: CKD is a signiﬁcant factor associated with UTUC. We should
pay attention to the possibility of UTUC for CKD patients before they
progress to ESRD.
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Purpose: We propose a formula of calculate-based contact surface area
(CSA). We examined the correlation of contact surface area and renal
volume loss and the predictability for renal function after partial
nephrectomy.
Materials and Methods: We conducted a retrospective study in pa-
tients who underwent partial nephrectomy between January 2012 and
December 2014. Based on abdominopelvic CT and MRI, we calculated
the contact surface area with the formula “2* p *Radius*Depth”; while
resected and ischemic volume (RAIV) was determined by the equation”
[2w 2^+3w(r+d)+6rd]*w*p)⁄3”. We evaluated the correlation between
CSA, RAIV and perioperative parameters. And we comparatively
analyzed the ability of CSA and RAIV to predict the reduction in renal
function.
Results: There were 35, 26, and 45 patients receiving OPN, LPN, RPN
respectively. The mean±SD contact surface area was 30.7±26.1 cm2, and
and the mean±SD RAIV was 19.1±14.4 cm3. On Spearman correlation
analysis we found that CSA and RAIV were highly correlated (coefﬁ-
cient: 0.99, p < 0.001). In univariate analysis, BMI (p¼ 0.02), EBL(p¼ 0.001), RAIV (p < 0.001), and CSA (p < 0.001) signiﬁcantly affected
postoperative renal function. In ROC curve analysis, both CSA and RAIV
have good ability to predict more than 10% change of estimated
glomerular ﬁltration rate (AUC: 0.86 vs. 0.87). There is no signiﬁcant
difference in AUC between CSA and RAIV. The area difference in PCE10
was 0.002 (p¼ 0.51).
Conclusion: In our study, CSA and RAIV were correlated with several
perioperative outcomes and affected post-operative renal function. The
ability to predict post-operative renal function between CSA and RAIV was
nearly identical. Since CSA was simpler to use, and may possess less
interobserver variability in comparison with RAIV, we believe that CSA can
represent renal parenchymal loss.
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Purpose: Urothelial carcinomas (UCs) involve recurrent chromosome 9p
deletions. Methylthioadenosine phosphorylase (MTAP) on 9p21.3is a pro-
posed functional tumor suppressor gene. The role of MTAP in upper tract
UC (UTUC) is unknown. We aimed to investigate MTAP's association with
disease characteristics and oncologic outcomes in UTUC patients under-
going radical nephroureterectomy (RNU).
Materials and Methods: Using immunohistochemistry, we investigated
MTAP expression in 340 UTUC patients treated with RNU from1996e2004,
and correlated it with clinicopathologic characteristics and clinical out-
comes. Univariate and multivariate Cox regression analyses evaluated the
association of MTAP expression with disease-speciﬁc survival (DSS) and
metastasis-free survival (MeFS).
Results:MTAP was deﬁcient in 119 (35.0%) patients. MTAP deﬁciency was
signiﬁcantly associated with higher pathologic stage (p< 0.001), lymph
node metastasis (p< 0.001), high grade (p¼ 0.008), vascular invasion
(p¼ 0.001), perineural invasion (p¼ 0.001), and higher mitotic rate
(p¼ 0.016).Sixty (17.6%) patients died of UTUC and 70 (20.6%) developed
metastasis. MTAP-deﬁcient patients demonstrated signiﬁcantly worse DSS
(58.1% vs.89.3%; p< 0.0001) and MeFS (54.7% vs.87.9%; p< 0.0001) at ﬁve
years than those with intact expression. MTAP deﬁciency was indepen-
dently associated with cancer-speciﬁc mortality (hazard ratio [HR]:2.213,
p¼ 0.019; 95% conﬁdence interval [CI]:1.141e4.293) and metastasis
development (HR:2.867, p< 0.001; 95% CI:1.601e5.106).
Conclusion: MTAP deﬁciency is associated with aggressive cancer
phenotype and unfavorable oncologic outcomes, suggesting it may be a
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